These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19291635)

  • 1. [Does JUPITER change the daily routine of our practice?].
    Schlossberg D
    Praxis (Bern 1994); 2009 Mar; 98(6):302. PubMed ID: 19291635
    [No Abstract]   [Full Text] [Related]  

  • 2. Another look at the results of the JUPITER trial.
    Kappagoda CT; Amsterdam EA
    Am J Cardiol; 2009 Dec; 104(11):1603-5. PubMed ID: 19932800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The JUPITER study].
    Gaspardone A; Maseri A
    G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosuvastatin in patients with elevated C-reactive protein.
    Gibbons RJ
    N Engl J Med; 2009 Mar; 360(10):1038; author reply 1041-2. PubMed ID: 19264695
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
    Jialal I; Smith G
    Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
    Ridker PM;
    Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence and critique of the JUPITER Trial (Statins v no statins for primary prevention of cardiovascular events in patients with normal lipids and elevated C-reactive protein).
    Samson RH; Nair DG
    Semin Vasc Surg; 2011 Sep; 24(3):172-9. PubMed ID: 22153029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JUPITER, rosuvastatin, and the European Medicines Agency.
    Ridker PM; Glynn RJ
    Lancet; 2010 Jun; 375(9731):2071. PubMed ID: 20494436
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 10. [CRP level as risk marker of cardiovascular disease?].
    Thelle DS; Arnesen E
    Tidsskr Nor Laegeforen; 2010 Mar; 130(5):512-4. PubMed ID: 20224622
    [No Abstract]   [Full Text] [Related]  

  • 11. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
    Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comment from the lipidologic viewpoint].
    Riesen WF
    Praxis (Bern 1994); 2009 Feb; 98(3):125-7. PubMed ID: 19180437
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U; Weintraub WS; Packard CJ
    Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract]   [Full Text] [Related]  

  • 15. (8) Cardiovascular disease and risk management.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
    [No Abstract]   [Full Text] [Related]  

  • 16. [JUPITER, what now?].
    Perna GP
    G Ital Cardiol (Rome); 2009 Dec; 10(11-12 Suppl 3):33S-38S. PubMed ID: 21298860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of statins and aspirin to reduce risks of cardiovascular disease.
    Hebert PR; Pfeffer MA; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):77-80. PubMed ID: 12075395
    [No Abstract]   [Full Text] [Related]  

  • 18. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 19. JUPITER study highlights C-reactive protein as a cardiac risk factor.
    Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral arterial procedures and postinterventional prophylaxis.
    Kröger K
    J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.